Publications by authors named "Melody Diamond"

Claim this Profile
A
An acute rat in vivo screening model to predict compounds that alter blood glucose and/or insulin regulation.
David A Brott, Melody Diamond, Pam Campbell, Andy Zuvich, Letitia Cheatham

J Pharmacol Toxicol Methods· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.
Steven D Knight, Nicholas D Adams, Joelle L Burgess, Amita M Chaudhari, Michael G Darcy, Melody A Diamond

ACS Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.
Kenneth W Wood, Latesh Lad, Lusong Luo, Xiangping Qian, Steven D Knight, Melody A Diamond

Proc Natl Acad Sci U S A· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.
Zilun Hu, Xiangjun Jiang, Charles F Albright, Nilsa Graciani, Eddy Yue, Melody Diamond

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.
Aidan G Gilmartin, Maureen R Bleam, Mark C Richter, Symon G Erskine, Ryan G Kruger, Melody A Diamond

Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ATP-competitive kinesin spindle protein inhibitors.
Cynthia A Parrish, Nicholas D Adams, Kurt R Auger, Joelle L Burgess, Jeffrey D Carson, Melody A Diamond

J Med Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
Charles F Albright, Nilsa Graciani, Wei Han, Eddy Yue, Ross Stein, Melody Diamond

Mol Cancer Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors.
Zhihong Lai, Tao Yang, Young B Kim, Thais M Sielecki, Melody A Diamond

Proc Natl Acad Sci U S A· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis